RAK Ceramics to Build Ceramic Tile Production Facility in India

UAE-based ceramic tile producer, RAK Ceramics has inked a Memorandum of Understanding with the Gujarat government to build a modern ceramic tile production facility in Gujarat, India.

The strategic investment of Rs 500 crores will strengthen RAK Ceramics footprint in the North-West market of the country. The new production facility will manufacture a broad range of tile products. The company will decrease its freight outward expenditure through this investment and could become one of the prominent ceramic tile producers in the west.

RAK Ceramics is currently producing nearly 12,000 sanitary ware units and approximately 360,000 m2 of vitrified and ceramic tiles every day. The first stage of production will begin in the Q1 of 2012. The company intends to export its ceramic tiles from the Gujarat plant in future and will explore associated investments in other fields.

The Chief Executive Officer of RAK Ceramics India, Sudhir Malesha stated that the company plans to invest the amount over a five-year period. The company has found out a site spanning 50 to 70 acres at Himmatnagar in Mehsana district. This proposal would create more jobs in the state.

Source: http://www.rakceramics.com

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Chai, Cameron. (2019, February 09). RAK Ceramics to Build Ceramic Tile Production Facility in India. AZoM. Retrieved on April 25, 2024 from https://www.azom.com/news.aspx?newsID=28514.

  • MLA

    Chai, Cameron. "RAK Ceramics to Build Ceramic Tile Production Facility in India". AZoM. 25 April 2024. <https://www.azom.com/news.aspx?newsID=28514>.

  • Chicago

    Chai, Cameron. "RAK Ceramics to Build Ceramic Tile Production Facility in India". AZoM. https://www.azom.com/news.aspx?newsID=28514. (accessed April 25, 2024).

  • Harvard

    Chai, Cameron. 2019. RAK Ceramics to Build Ceramic Tile Production Facility in India. AZoM, viewed 25 April 2024, https://www.azom.com/news.aspx?newsID=28514.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.